DNA methylation signatures of illicit drug injection and hepatitis C are associated with HIV frailty
Xinyu Zhang,
Ying Hu,
Amy C Justice,
Boyang Li,
Zuoheng Wang,
Hongyu Zhao,
John H Krystal and
Ke Xu ()
Additional contact information
Xinyu Zhang: Yale School of Medicine
Ying Hu: National Cancer Institute Center for Biomedical Information & Information Technology
Amy C Justice: VA Connecticut Healthcare System
Boyang Li: Yale School of Public Health
Zuoheng Wang: Yale School of Public Health
Hongyu Zhao: Yale School of Public Health
John H Krystal: Yale School of Medicine
Ke Xu: Yale School of Medicine
Nature Communications, 2017, vol. 8, issue 1, 1-11
Abstract:
Abstract Intravenous illicit drug use (IDU) and hepatitis C infection (HCV) commonly co-occur among HIV-infected individuals. These co-occurring conditions may produce interacting epigenetic effects in white blood cells that influence immune function and health outcomes. Here, we report an epigenome-wide association analysis comparing IDU+/ HCV+ and IDU−/HCV− in 386 HIV-infected individuals as a discovery sample and in 412 individuals as a replication sample. We observe 6 significant CpGs in the promoters of 4 genes, NLRC5, TRIM69, CX3CR1, and BCL9, in the discovery sample and in meta-analysis. We identify 19 differentially methylated regions on chromosome 6 harboring MHC gene clusters. Importantly, a panel of IDU+/HCV+-associated CpGs discriminated HIV frailty based upon a validated index with an area under the curve of 79.3% for high frailty and 82.3% for low frailty. These findings suggest that IDU and HCV involve epigenetic programming and that their associated methylation signatures discriminate HIV pathophysiologic frailty.
Date: 2017
References: Add references at CitEc
Citations:
Downloads: (external link)
https://www.nature.com/articles/s41467-017-02326-1 Abstract (text/html)
Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.
Export reference: BibTeX
RIS (EndNote, ProCite, RefMan)
HTML/Text
Persistent link: https://EconPapers.repec.org/RePEc:nat:natcom:v:8:y:2017:i:1:d:10.1038_s41467-017-02326-1
Ordering information: This journal article can be ordered from
https://www.nature.com/ncomms/
DOI: 10.1038/s41467-017-02326-1
Access Statistics for this article
Nature Communications is currently edited by Nathalie Le Bot, Enda Bergin and Fiona Gillespie
More articles in Nature Communications from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().